Becton Dickinson Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Becton Dickinson de 17.4% y 5.3% por año respectivamente. Se prevé que el BPA crezca en un 18.1% al año. Se espera que la rentabilidad financiera sea de 15.4% en 3 años.
Información clave
17.6%
Tasa de crecimiento de los beneficios
18.1%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 16.1% |
| Tasa de crecimiento de los ingresos | 5.4% |
| Rentabilidad financiera futura | 15.4% |
| Cobertura de analistas | Good |
| Última actualización | 23 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)
Mar 23
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)
Feb 29Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings
Feb 08Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 03These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Feb 01Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play
Jan 22Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 30Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24
Nov 13Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's
Nov 12Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price
Nov 06With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case
Oct 05Becton, Dickinson Stock Is A Hold, Here's Why
Oct 04Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers
Aug 30We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Aug 13Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Jul 28Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching
Jun 22Becton, Dickinson and Company: Still Not Very Healthy
Jun 20Becton, Dickinson: Business Should Beat H2 2023 Expectations
Jun 08These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Apr 22Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?
Mar 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Mar 05Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use
Feb 21Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test
Feb 08Becton, Dickinson Q1 2023 Earnings Preview
Feb 01Becton, Dickinson declares $0.91 dividend
Jan 24We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Jan 09CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod
Jan 09Becton, Dickinson: A Quality Defensive Pick For 2023
Dec 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Dec 01Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91
Nov 13Becton, Dickinson Q4 2022 Earnings Preview
Nov 09Becton, Dickinson, Biocorp team up for traceability of injectable drugs
Oct 18Becton, Dickinson: Buy In Now While You Can
Oct 12Does Becton Dickinson (NYSE:BDX) Have A Healthy Balance Sheet?
Oct 05BD, Certest Biotec launch monkeypox test
Sep 26Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 9/30/2026 | 22,705 | 2,665 | 4,095 | 5,062 | 7 |
| 9/30/2025 | 21,502 | 2,543 | 3,748 | 4,684 | 14 |
| 9/30/2024 | 20,311 | 2,105 | 4,077 | 4,693 | 14 |
| 12/31/2023 | 19,492 | 1,265 | 2,649 | 3,431 | N/A |
| 9/30/2023 | 19,372 | 1,470 | 2,115 | 2,989 | N/A |
| 6/30/2023 | 19,046 | 1,582 | 1,878 | 2,773 | N/A |
| 3/31/2023 | 18,809 | 1,556 | 1,144 | 2,101 | N/A |
| 12/31/2022 | 18,738 | 1,486 | 1,361 | 2,359 | N/A |
| 9/30/2022 | 18,870 | 1,545 | 1,661 | 2,634 | N/A |
| 6/30/2022 | 18,958 | 1,412 | 1,465 | 2,575 | N/A |
| 3/31/2022 | 18,924 | 1,430 | 2,041 | 3,141 | N/A |
| 12/31/2021 | 18,534 | 1,079 | 2,620 | 3,751 | N/A |
| 9/30/2021 | 19,131 | 1,514 | 3,453 | 4,647 | N/A |
| 6/30/2021 | 19,066 | 1,486 | 4,222 | 5,177 | N/A |
| 3/31/2021 | 18,313 | 1,379 | 4,150 | 5,064 | N/A |
| 12/31/2020 | 18,207 | 1,507 | 3,476 | 4,359 | N/A |
| 9/30/2020 | 16,074 | 245 | 2,728 | 3,497 | N/A |
| 6/30/2020 | 16,917 | 786 | 2,474 | 3,429 | N/A |
| 3/31/2020 | 17,414 | 923 | 2,509 | 3,499 | N/A |
| 12/31/2019 | 17,355 | 760 | 2,835 | 3,798 | N/A |
| 9/30/2019 | 17,290 | 1,081 | 2,373 | 3,330 | N/A |
| 6/30/2019 | 17,108 | 784 | 2,359 | 3,265 | N/A |
| 3/31/2019 | 17,036 | 926 | 2,009 | 2,875 | N/A |
| 12/31/2018 | 17,063 | 894 | 1,906 | 2,790 | N/A |
| 9/30/2018 | 15,983 | 159 | 1,970 | 2,865 | N/A |
| 6/30/2018 | 14,747 | 621 | 1,837 | 2,685 | N/A |
| 3/31/2018 | 13,503 | -99 | 1,681 | 2,527 | N/A |
| 12/31/2017 | 12,251 | 294 | 1,762 | 2,555 | N/A |
| 9/30/2017 | 12,093 | 1,030 | N/A | 2,550 | N/A |
| 6/30/2017 | 12,158 | 759 | N/A | 2,129 | N/A |
| 3/31/2017 | 12,321 | 1,314 | N/A | 2,579 | N/A |
| 12/31/2016 | 12,419 | 1,309 | N/A | 2,411 | N/A |
| 9/30/2016 | 12,483 | 976 | N/A | 2,559 | N/A |
| 6/30/2016 | 12,312 | 1,139 | N/A | 2,532 | N/A |
| 3/31/2016 | 12,234 | 810 | N/A | 2,236 | N/A |
| 12/31/2015 | 11,217 | 688 | N/A | 1,907 | N/A |
| 9/30/2015 | 10,282 | 695 | N/A | 1,730 | N/A |
| 6/30/2015 | 9,410 | 815 | N/A | 1,591 | N/A |
| 3/31/2015 | 8,448 | 1,079 | N/A | 1,492 | N/A |
| 12/31/2014 | 8,468 | 1,150 | N/A | 1,677 | N/A |
| 9/30/2014 | 8,446 | 1,185 | N/A | 1,746 | N/A |
| 6/30/2014 | 8,345 | 974 | N/A | 1,876 | N/A |
| 3/31/2014 | 8,239 | 941 | N/A | 1,830 | N/A |
| 12/31/2013 | 8,169 | 930 | N/A | 1,626 | N/A |
| 9/30/2013 | 8,054 | 929 | N/A | 1,505 | N/A |
| 6/30/2013 | 7,920 | 1,114 | N/A | 1,405 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (17.4% al año) de BDX es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (17.4% al año) de BDX crezcan más rápidamente que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de BDX crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (5.3% al año) de BDX crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 5.3% al año) de BDX crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de BDX sea baja dentro de 3 años (15.4%).